🔎 Trials Near Me

Gara Jalqabaatti › Myelodysplastic Syndromes › Ohio › Columbus

Qorannoo klinikaalii Myelodysplastic Syndromes Columbus, OH keessatti

Qorannoo 14 Myelodysplastic Syndromes f Columbus fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564390

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06577441

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Namoota walitti qabaa jiraSadarkaa 1/2
  • The Ohio State University, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05320198

Collection of Tissue Samples for Cancer Research

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Ohio State University, Columbus
2 Months · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT00900198

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

Namoota walitti qabaa jiraSadarkaa 1
  • Ohio State University, The James Comprehensive Cancer, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06846606

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

Namoota walitti qabaa jiraSadarkaa 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06465953

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

Namoota walitti qabaa jiraSadarkaa 1/2
  • The Ohio State University Comprehensive Cancer Center, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT05308264

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Namoota walitti qabaa jiraSadarkaa 2/3
  • Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Elb-2026 · NCT04256317

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Namoota walitti qabaa jiraSadarkaa 1
  • Ohio State University Medical Center, Columbus
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 25-Bit-2026 · NCT03533816

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Namoota walitti qabaa jiraSadarkaa 1/2
  • The Ohio State University Comprehensive Cancer Center, Columbus
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 24-Bit-2026 · NCT04988555

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Columbus
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 1
  • The Ohio State University Wexner Medical Center - James Cancer Hosp, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2025 · NCT06501196

HPC Offered for PRESERVE Expansion

Namoota walitti qabaa jiraQorannoo ilaalaa
  • The Ohio State University Medical Center, Columbus
Umuriin 12 hanga 80 · Saalaa hunda · Haaromfame 28-Hag-2025 · NCT07145411

Qorannoo Myelodysplastic Syndromes magaalota biroo keessatti

Qorannoo biroo Columbus keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.